Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors

Title
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume 30, Issue 6, Pages 2318-2326
Publisher
Springer Nature
Online
2012-01-03
DOI
10.1007/s10637-011-9772-8

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started